Governor Brown signed Senate Bill 17 on Monday, overcoming opposition from the pharmaceutical industry to bring more accountability and transparency to drug pricing. The bill requires health plans and insurers, beginning January 2019, to provide the state with data on the percentage of premiums and increases in premiums that can be attributed to prescription drug costs, and calls for drug manufacturers to notify health plans and insurers at least 60 days before increasing the price of drugs whose wholesale cost is at least $40. To read more, go to